American Renal Associates Holdings,Inc. (NYSE:ARA) Files An 8-K Other Events

0

American Renal Associates Holdings,Inc. (NYSE:ARA) Files An 8-K Other Events
Item 8.01. Other Events

On January 3, 2017, the Company received a subpoena from the U.S. Department of Justice (“DOJ”), dated December 30, 2016, requesting information relating to the Company’s interactions with the American Kidney Fund (“AKF”) and certain topics related to applicable healthcare laws for the period from January 1, 2013 through the present. As it has done with the other regulators who have expressed interest in such matters, the Company intends to fully cooperate in responding to this request.

No assurance can be given as to the timing or outcome of this matter, nor can any assurance be given as to whether this matter will affect the Company’s other relationships, or the Company’s business generally.  In addition, we may in the future be subject to additional inquiries, litigation or other proceedings or actions, regulatory or otherwise, arising in relation to the matter described above and related litigation and investigative matters previously disclosed.  An unfavorable outcome of any such inquiry, litigation or proceeding or action could have a material adverse effect on our business, financial condition and results of operations.



About American Renal Associates Holdings, Inc. (NYSE:ARA)

American Renal Associates Holdings, Inc. is a dialysis services provider in the United States. The Company focuses on joint venture partnerships with physicians. The Company’s segment is the ownership and operation of dialysis clinics. It provides patient care and clinical outcomes to patients suffering from the advanced stage of chronic kidney disease, known as end stage renal disease (ESRD). It operates clinics through a joint venture (JV) model, in which it partners with local nephrologists to develop, own and operate dialysis clinics. Each of its clinics is maintained as a separate joint venture in which it has the controlling interest, and its nephrologist partners and other joint venture partners have a non-controlling interest. The Company opens over 20 de novo clinics each year. The Company has owned and operated over 190 dialysis clinics in partnership with approximately 350 nephrologist partners treating over 13,000 patients in over 20 states and the District of Columbia.

American Renal Associates Holdings, Inc. (NYSE:ARA) Recent Trading Information

American Renal Associates Holdings, Inc. (NYSE:ARA) closed its last trading session up +1.31 at 23.05 with 160,558 shares trading hands.